Cynthia Dancey, PA
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 387 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 38 manufacturers, the largest accounting for just 11.8% — the pattern of someone who eats at a lot of different presentations. 2025 is the largest year on record at $2,418, 2.0 times the $1,183 reported in 2021. Among medical clinicians in MO with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 387 payments — averaging $19.65 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$900
- Lilly USA, LLC$875
- Novo Nordisk$861
- Pfizer$665
- AbbVie$502
- Axsome Therapeutics, Inc.$438
- plus $3K from 32 others
What the payments were for
- Food & beverage$7,603100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca(2 entities) | 37 | $900 |
| Lilly USA, LLC | 54 | $875 |
| Novo Nordisk | 39 | $861 |
| Pfizer | 55 | $665 |
| AbbVie | 33 | $502 |
| Axsome Therapeutics, Inc. | 17 | $438 |
| Takeda Pharmaceuticals U.S.A., Inc. | 29 | $408 |
| GSK | 13 | $374 |
| Amgen | 9 | $222 |
| Abbott | 9 | $199 |
| Biohaven Pharmaceuticals, Inc. | 6 | $195 |
| Boehringer Ingelheim | 12 | $179 |
| Biohaven Pharmaceutical Holding Company Ltd. | 5 | $171 |
| Otsuka America Pharmaceutical, Inc. | 10 | $160 |
| Daiichi Sankyo Inc. | 4 | $156 |
| Sanofi | 1 | $148 |
| Dexcom, Inc. | 7 | $136 |
| Kyowa Kirin, Inc. | 1 | $125 |
| Neurocrine Biosciences, Inc. | 1 | $108 |
| Eisai Inc. | 6 | $95 |
| Astellas Pharma US Inc | 5 | $92 |
| Madrigal Pharmaceuticals | 1 | $88 |
| Supernus Pharmaceuticals, Inc. | 5 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $59 |
| Exact Sciences | 4 | $56 |
| Merck | 3 | $44 |
| Lundbeck LLC | 3 | $42 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $33 |
| Bayer | 2 | $27 |
| Kowa Pharmaceuticals America, Inc. | 2 | $27 |
| Teva Pharmaceuticals USA, Inc. | 2 | $23 |
| Idorsia Pharmaceuticals US Inc | 1 | $22 |
| Viatris Specialty LLC | 1 | $20 |
| Inspire Medical Systems, Inc. | 1 | $19 |
| Medtronic | 1 | $16 |
| Organon | 1 | $15 |
| Sanofi-aventis U.S. LLC | 1 | $15 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Ozempic$249
- NURTEC ODT$218
- FABRAZYME$148
- CRYSVITA$125
- Auvelity$114
- INGREZZA$108
- TRELEGY ELLIPTA$103
- Otezla$101
How this compares
$7,603 in reported general payments places this provider in the 90th percentile of 198 medical providers in Missouri.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 58 | $53,379 |
| MounjaroTirzepatide | 35 | $40,559 |
| JardianceEmpagliflozin | 41 | $34,954 |
| XareltoRivaroxaban | 29 | $27,486 |
| OzempicSemaglutide | 20 | $19,223 |
| MyrbetriqMirabegron | 25 | $18,735 |
| FarxigaDapagliflozin Propanediol | 20 | $17,096 |
| Spiriva RespimatTiotropium Bromide | 13 | $6,870 |
| Combivent RespimatIpratropium/Albuterol Sulfate | 13 | $6,403 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 50 | $4,860 |
| Gabapentin | 124 | $3,543 |
| ArexvyRsvpref3 Antigen/As01e/Pf | 12 | $3,209 |
| Fluticasone-SalmeterolFluticasone Propion/Salmeterol | 22 | $2,692 |
| Budesonide-Formoterol FumarateBudesonide/Formoterol Fumarate | 18 | $2,257 |
| VascepaIcosapent Ethyl | 11 | $1,836 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $665 | $53,37958 claims |
| Boehringer IngelheimJardiance, Spiriva Respimat, Combivent Respimat | $179 | $48,22767 claims |
| Lilly USA, LLCMounjaro | $875 | $40,55935 claims |
| Novo NordiskOzempic | $861 | $19,22320 claims |
| Astellas Pharma US IncMyrbetriq | $92 | $18,73525 claims |
| AstraZenecaFarxiga | $900 | $17,09620 claims |
| GSKArexvy | $374 | $3,20912 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 198 medical providers in Missouri.
Other medical in Ozark
- Sarah FastOzark$7K
- Melanie ChisamSpringfield$92K
- Emily JensenBowling Green$51K
- Sarah WilmsmeyerChesterfield$22K
- Amy MosmanSaint Louis$21K
- Dustin BartlettSpringfield$21K
- Alexa Fider-WhyteSaint Louis$18K
- Megan Isaacson-SchmidSaint Louis$16K
- Erin YoffieSaint Louis$16K
- Corey WhitesidesColumbia$15K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.